The SBC signature was significantly enriched in samples with higher breast cancer risk (i.e., nulliparous, and BRCA1/2mut carriers) compared to those of lower risk (FDR < 0.05 for all cases, Fig. 4e). Here, BRCA1 is linked to breast cancer.